Table 1 |
|||
|
Availability of information on the methods used in recording ADRs, categorized according to type of ADRs reported by the trial. |
|||
|
Types of ADRs |
No. of trials |
Specific details given on how |
Did not specify methods |
|
reporting |
rate of reported ADRs were |
used in determining the |
|
|
recorded |
rate of reported ADRs |
||
|
|
|||
|
Detected by |
68 |
37 (55%) |
31 (45%) |
|
investigative tests |
|||
|
Clinical events |
95 |
14 (15%) |
81 (85%) |
|
Patient symptoms |
104 |
18 (17%) |
86 (83%) |
|
|
|||
|
Loke and Derry BMC Clinical Pharmacology 2001 1:3 doi:10.1186/1472-6904-1-3 |
|||
